Porzio Life Sciences provides Aggregate Spend Regulatory Compliance software solutions for Pharmaceutical, Medical Device & Biotech companies comply with Affordable Care Act and Sunshine Act.
HomeProducts & ServicesMedia LibraryAbout UsContact UsSubscriber LoginGoToMeetingBlog

About Us


Jeffrey Campbell, John Oroho, and Christine Bradshaw Attended 5th Annual Summit on Disclosure for Drug, Device and Biotech Companies

The Ritz-Carlton
Washington, D.C.

February 19-21, 2013


D. Jeffrey Campbell, John Patrick Oroho, and Christine Bradshaw were panelists at PCF's 5th Annual Summit on Disclosure for Drug, Device and Biotech Companies in Washington D.C. on February 19-21, 2013.

The Summit provided a comprehensive update of the rapidly evolving transparency requirements now taking shape across the globe and offered timely advice on creating a global aggregate spend and disclosure program.  Additionally, it offered pharmaceutical and medical device professionals the first opportunity to assess the Final Rule for the Physician Payments Sunshine Act with the help of senior government regulators, as well as an array of industry experts and leading consultants who have been in the vanguard of building and implementing aggregate spend solutions

Campbell, Oroho, and Bradshaw addressed topics pertaining to Federal and state drug samples disclosure requirements.

For more information about the Summit, please click here.


Contact Us - Porzio Request more information or call 973.538.1690
  << Back